Journey Medical Corporation Reports Full-Year 2021 Financial Results and Recent Corporate Highlights
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce CUTX-101, Copper Histidinate, Data to be Presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting
Journey Medical Corporation to Release Year End 2021 Financial Results and Provide Corporate Update on March 23, 2022
Cantor Fitzgerald’s Rare Orphan Disease Summit
Stay informed and receive company updates straight to your inbox.